✦ LIBER ✦

Cisplatin, epirubicin and paclitaxel combination chemotherapy in previously untreated patients with advanced epithelial ovarian cancer

✍ Scribed by C. Papadimitriou; D. Lazaris; A. Rodolakis; C. Kiamouris; G.M. Gourgoulis; E. Galani; E. Diakomanolis; S. Michalas; M.A. Dimopoulos

Book ID: 117123760
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 157 KB
Volume: 70
Category: Article
ISSN: 0020-7292
DOI: 10.1016/s0020-7292(00)81917-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel, cisplatin and epirubicin (PC

Paclitaxel, cisplatin and epirubicin (PCE) combination chemotherapy for newly diagnosed patients with advanced epithelial ovarian cancer (AEOC)

✍ C. Papadimitriou; A. Anagnostopoulos; Z. Voulgaris; G. Vlahos; E. Kioses; T. Akr 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Paclitaxel and Cisplatin Combination Che

Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent Epithelial Ovarian Cancer

✍ Jeffrey M. Goldberg; M.Steven Piver; Ronald E. Hempling; Fernando O. Recio 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 83 KB

A Phase I Study of Paclitaxel, Doxorubic

A Phase I Study of Paclitaxel, Doxorubicin, and Cisplatin in Patients with Previously Untreated Epithelial Ovarian Cancer

✍ R.Wendel Naumann; Ronald D. Alvarez; George A. Omura; Ellen Segars; Larry C. Kil 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Single-agent paclitaxel in patients with

Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer

✍ Gore, ME; Rustin, G; Slevin, M; Gallagher, C; Penson, R; Osborne, R; Ledermann, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 927 KB

Peripheral Neuropathy Due to Biweekly Pa

Peripheral Neuropathy Due to Biweekly Paclitaxel, Epirubicin and Cisplatin in Patients with Advanced Ovarian Cancer

✍ T.J. Postma; K. Hoekman; J.M.G.H. van Riel; J.J. Heimans; J.B. Vermorken 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 40 KB

Ifosfamide, paclitaxel and cisplatin fir

Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer

✍ Christos A. Papadimitriou; Charalambos Kouroussis; Lia A. Moulopoulos; Georgios 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## BACKGROUND. The combination of paclitaxel with a platinum analogue is the preferred chemotherapy regimen in the treatment of advanced epithelial ovarian carcinoma. The alkylating agent ifosfamide has shown activity in refractory or recurrent ovarian cancer. We conducted a Phase II study with th